BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
65 results:

  • 1. Clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.
    Lee JE; Kim J; Hwang M; Kim YH; Chung MJ; Jeong WG; Jeong YJ
    Korean J Radiol; 2024 May; 25(5):481-492. PubMed ID: 38627873
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incidence, prognostic factors, and a nomogram of cervical cancer with lung metastasis: A SEER-based study.
    Shan Y; Ding Z; Chen A; Cui Z
    J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102757. PubMed ID: 38403266
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Changes in the pulmonary function of CT-guided microwave ablation for patients with malignant lung tumors.
    Li Z; Zhao F; Wang G; Xue G; Wang N; Cao P; Hu Y; Wei Z; Ye X
    J Cancer Res Ther; 2023 Dec; 19(6):1669-1674. PubMed ID: 38156936
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
    Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
    Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Takeuchi E; Kondo K; Okano Y; Ichihara S; Kunishige M; Kadota N; Machida H; Hatakeyama N; Naruse K; Ogino H; Nokihara H; Shinohara T; Nishioka Y
    Thorac Cancer; 2023 Oct; 14(30):3042-3050. PubMed ID: 37669914
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer ≤ 2 cm: a systematic review and patient-level meta-analysis.
    Fong KY; Chan YH; Chia CML; Agasthian T; Lee P
    Updates Surg; 2023 Dec; 75(8):2343-2354. PubMed ID: 37563486
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study.
    Chen YT; Yeh HC; Lee HY; Hsieh PF; Chou EC; Tsai YC; Hong JH; Huang CY; Jiang YH; Lee YK; Tseng JS; Yu CC; Chiang BJ; Hsueh TY; Wu CC; Tsai CY
    Asian J Surg; 2023 Aug; 46(8):3058-3065. PubMed ID: 37525448
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Microbiomes Detected by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing among HIV-Infected and Uninfected Patients with Pulmonary Infection.
    Tan Y; Chen Z; Zeng Z; Wu S; Liu J; Zou S; Wang M; Liang K
    Microbiol Spectr; 2023 Aug; 11(4):e0000523. PubMed ID: 37436163
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Infectious Complications in Patients With Non-small Cell lung cancer Treated With Immune Checkpoint Inhibitors.
    Guo MZ; Balaji A; Murray JC; Reuss JE; Steinke SM; Bennett K; Naidoo J
    Clin Lung Cancer; 2023 Nov; 24(7):613-620. PubMed ID: 37419702
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical features and related factors of invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease].
    Zhang XH; Zhou C; Luo YM; Ge HQ; Liu HG; Wei HL; Zhang JC; Pan PH; Li XH; Zhou H; Cheng LN; Yi MQ; Zhang JR; Adila A; Peng LG; Liu Y; Pu JQ; Liu L; Feng HP; Zhou HX; Yi Q
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1692-1699. PubMed ID: 37302977
    [No Abstract]    [Full Text] [Related]  

  • 11. [Development and validation of prognostic nomogram for malignant pleural mesothelioma].
    Xie XJ; Chen JY; Jiang J; Duan H; Wu Y; Zhang XW; Yang SJ; Zhao W; Shen SS; Wu L; He B; Ding YY; Luo H; Liu SY; Han D
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):415-423. PubMed ID: 37188627
    [No Abstract]    [Full Text] [Related]  

  • 12. Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial.
    Lu S; Wu L; Jian H; Cheng Y; Wang Q; Fang J; Wang Z; Hu Y; Han L; Sun M; Miao L; Ding C; Cui J; Wang K; Li B; Li X; Ye F; Liu A; Pan Y; Cang S; Zhou H; Sun X; Shen Y; Wang S; Zhang W; He Y
    Lancet Respir Med; 2023 Jul; 11(7):624-636. PubMed ID: 37156249
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bioactive C21 Steroidal Glycosides from
    Feng X; Li J; Li H; Chen X; Liu D; Li R
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985801
    [No Abstract]    [Full Text] [Related]  

  • 14. Organ Transplants From Deceased Donors With Primary Brain Tumors and Risk of cancer Transmission.
    Greenhall GHB; Rous BA; Robb ML; Brown C; Hardman G; Hilton RM; Neuberger JM; Dark JH; Johnson RJ; Forsythe JLR; Tomlinson LA; Callaghan CJ; Watson CJE
    JAMA Surg; 2023 May; 158(5):504-513. PubMed ID: 36947028
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Dietz MV; Ziekman MJ; van Kooten JP; Brandt-Kerkhof ARM; van Meerten E; Verhoef C; Madsen EVE
    Ann Surg Oncol; 2023 Apr; 30(4):2048-2056. PubMed ID: 36566258
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression.
    Kim CM; Lee JB; Shin SJ; Ahn JB; Lee M; Kim HS
    ESMO Open; 2022 Oct; 7(5):100577. PubMed ID: 36156450
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
    Wen Q; Ge J; Lei Y; Zhang Y; Kong X; Wang W; Hou H; Wang Z; Qian S; Ding M; Dong M; Zhu L; Zhang M; Zhang X; Chen Q
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3989-4003. PubMed ID: 36030432
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. lung cancer-Specific Mortality Risk and Public Health Insurance: A Prospective Cohort Study in Chongqing, Southwest China.
    Wang Y; Lei H; Li X; Zhou W; Wang G; Sun A; Wang Y; Wu Y; Peng B
    Front Public Health; 2022; 10():842844. PubMed ID: 35570974
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Effects of family-oriented dignity therapy on dignity, depression and spiritual well-being of patients with lung cancer undergoing chemotherapy: A randomised controlled trial.
    Xiao J; Chow KM; Choi KC; Ng SNM; Huang C; Ding J; Chan WHC
    Int J Nurs Stud; 2022 May; 129():104217. PubMed ID: 35339908
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inhibition of the Na
    Shandell MA; Capatina AL; Lawrence SM; Brackenbury WJ; Lagos D
    J Biol Chem; 2022 Mar; 298(3):101707. PubMed ID: 35150740
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.